The FDA has just authorized a start-up to use the Apple Watch as a monitoring tool for Parkinson’s disease.
Tim Cook has said a few times that one of Apple’s greatest contributions to humanity is advancements in healthcare. Although it may sometimes seem grandiose or pompous, Apple continues to push forward. Continuous improvements built into the capabilities of its devices are setting new frontiers in how devices can help us.
A start-up on the move
The American start-up (specializing in the analysis of brain and neural data) Rune Labs has just received special authorization from the FDA (Food and Drug Administration). The latter authorizes him to use the Apple Watch for the purpose of monitoring certain symptoms in patients with Parkinson’s disease. Thanks to this, it will be able to collect and make available information relating to the health of patients.
An analysis of the tremors
The start-up’s StrivePD platform will use Apple Watch motion sensors to monitor and analyze tremors in certain patients. The data is all collected in an iPhone app, which allows patients to record their symptoms and track their treatment.
To complete her analysis, she will also combine these readings with information from other sources, such as a Medtronic implant to measure brain signals.
It’s a safe bet that this news will give a boost to efforts to detect the early signs of Parkinson’s disease. As a reminder, in Belgium, Parkinson’s disease affects around 30,000 people.
Follow Belgium-iphone on Facebook, Youtube and Instagram so you don’t miss any news, tests and tips.